SiBone (NASDAQ:SIBN) versus Edap Tms (NASDAQ:EDAP) Head-To-Head Comparison

Edap Tms (NASDAQ:EDAP) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a summary of recent ratings for Edap Tms and SiBone, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	1	2	0	0	1.67
SiBone	1	0	6	0	2.71

Edap Tms presently has a consensus price target of $2.00, indicating a potential downside of 41.00%. SiBone has a consensus price target of $24.67, indicating a potential upside of 88.01%. Given SiBone’s stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Edap Tms.

Volatility and Risk

Edap Tms has a beta of -0.09, meaning that its stock price is 109% less volatile than the S&P 500. Comparatively, SiBone has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.

Insider and Institutional Ownership

62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 98.1% of SiBone shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Comparatively, 4.0% of SiBone shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Edap Tms and SiBone’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Edap Tms	-41.24%	-100.07%	-37.38%
SiBone	-9.41%	-11.01%	-8.12%

Earnings & Valuation

This table compares Edap Tms and SiBone”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$70.53 million	1.80	-$29.25 million	($0.77)	-4.40
SiBone	$200.93 million	2.88	-$18.90 million	($0.44)	-29.82

SiBone has higher revenue and earnings than Edap Tms. SiBone is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Summary

SiBone beats Edap Tms on 13 of the 14 factors compared between the two stocks.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

About SiBone

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.